In last trading session, BioAge Labs Inc (NASDAQ:BIOA) saw 0.28 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $5.09 trading at -$0.27 or -5.04% at ring of the bell on the day assigns it a market valuation of $182.47M. That closing price of BIOA’s stock is at a discount of -422.99% from its 52-week high price of $26.62 and is indicating a premium of 24.36% from its 52-week low price of $3.85. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.52 million shares which gives us an average trading volume of 752.03K if we extend that period to 3-months.

BioAge Labs Inc (NASDAQ:BIOA) trade information

Upright in the red during last session for losing -5.04%, in the last five days BIOA remained trading in the red while hitting it’s week-highest on Thursday, 01/02/25 when the stock touched $5.09 price level, adding 15.45% to its value on the day. BioAge Labs Inc’s shares saw a change of -12.09% in year-to-date performance and have moved -12.09% in past 5-day. BioAge Labs Inc (NASDAQ:BIOA) showed a performance of -74.66% in past 30-days. Number of shares sold short was 1.35 million shares which calculate 1.45 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 40 to the stock, which implies a rise of 87.27% to its current value. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 45. It follows that stock’s current price would drop -37.52% in reaching the projected high whereas dropping to the targeted low would mean a loss of -37.52% for stock’s current value.